Divízia imunotestov spoločnosti Biomedica spustila svoj vlastný výskumný a vývojový program v roku 1988 a teraz vyrába rad inovačných imunotestov pre klinický výskum v oblasti kardiorenálnych ochorení a minerálnych a kostných porúch.

Stanovujeme štandard pre klinický výskum pomocou kalibrátorov对环境的控制，是对生物制品的控制。 Dodávané 免疫测试 sú plne validované。预配合辐射波拉维特沃伦·塞洛斯维托夫分布：心脏病、骨病、肾病和肿瘤。整个过程按照 ISO 9001:2008 和 GMP/GLP 标准进行。 Skúsený a kvalifikovaný tím odborníkov spoločnosti Biomedica poskytuje technickú a vedeckú podporu。

#Biomedica 很高兴向您介绍新一代#Plate #Reader。 #Absorbance96 是一款设计独特的固态 #microplatereader，具有 96 个检测单元，由德国 #lifescience 公司 Byonoy 开发。尽管其外形紧凑，Absorbance 96 却能以实惠的价格提供精确且准确的结果。其便携性可实现现场读数，无需 #sample #transport。多种可用波长组合可实现广泛的终点和动力学分析。主要特点• 节省空间的设计• 基于滤光片的系统• 4 波长通道，405 - 650 nm• 快速读出速度• 可靠的测量结果• 维护-免费• 用户友好的软件• ELISA、蛋白质和细胞检测

25/08/2022

05/04/2023

30/03 /2023

14/06/2022

08/02/2023

Biomedica 于 40 多年前在维也纳成立，是医疗设备、体外诊断、生命科学产品、生物医学免疫测定和临床 IT 的领先分销商。

请点击：生物医学品牌视频

2022年8月25日

2023年5月4日

2023/03/30

2022/06/14

2023/08/02< /p>

您在欧洲寻找诊断经销商吗？ AddLife Labtech Diagnostic 在 29 个欧洲国家拥有 342 名专业销售人员。我们拥有受过高等教育、在各个领域拥有多年经验的敬业员工。欢迎在这里与我们配对！

AddLife Labtech 诊断小组：Bio-Connect、BIOMEDICA Medizinprodukte GmbH、Euroclone、Healthcare21、Immuno Diagnostic 和 Triolab Group。

25/08/2022

05/04/2023

30/ 03/2023

14/06/2022

08/02/2023

您在欧洲寻找诊断经销商吗？ AddLife Labtech Diagnostic 在 29 个欧洲国家拥有 104 名客户支持。欢迎在这里进行配对！

25/08/2022

05/04/2023

30/03/2023

14 /06/2022

2023/08/02

分析服务 – Biomedica – 可靠且灵活 Biomedica 为您的样品测量提供定制分析测试服务：ELISA、Luminex、microRNA、糖谱分析和 NGS。了解更多信息：https://www.bmgrp.com/analytical-services-biomedica/ BIOMEDICA 分析服务• 灵活 - 根据您的项目需求定制• 快速 - 快速周转时间以满足您的截止日期

2022年8月25日

2023年5月4日

2023/03/30

2022/06/14

2023/08/02

我们40 多年来，我们一直是医疗器械分销、体外诊断、生命科学产品、生物医学免疫分析和临床 IT 领域的领先公司。这家在维也纳成立的小企业现已发展成为一家跨国公司。

BIOMEDICA Medizinprodukte GmbHDivischgasse 4 / 1210 Wien / ÖsterreichT +43 1 291 07Fax +43 1 290 14 29office(at)bmgrp.at

Tim zadužen za aplikaciju pruža podršku našemlokalnom prodajnom timu i našim korisnicima。 Oni su uključeni u obuku oproizvodima, a odgovorni su i za 解决问题和 odgovaranje na pitanjakoja se odnose na proizvod。 Servisno odeljenje bavi se montažom i održavanjemuređaja kao i popravkom neispravnih instrumenata。 Ova jedinstvena kombinacijatehničke podrške omogućava nam da budemo vrlo fleksibilni i odgovorni usvakodnevnim situacijama。

Naše odeljenje za aplikaciju i service prva jelinija podrške za eventualne issues ili specična pitanja or našiminstrument ima，setovima ili procesima。 Stručnjaci za prodaju、applikaciju iservis blisko sarađuju kako bi obezbedili dobro Organizovanu podršku。

Odeljenje Biomedica 免疫分析研究项目 istraživanja i razvoja 1988。godine i sata proizvodi nizinovativnih imunoloških testova za klinička istraživanja u oblastikardiorenalnih bolesti kao i poremećajaminerala i kostiju。

Postavljamo 标准校准和控制的 Klinička istraživanjapomoću巴兹血清、 omogućujući tako istraživačima daprikupe biološki pouzdane podatke。 Isporučeni imunološki testovi u potpunostisu validirani。我们的研究成果包括：心脏学、骨学、肾学和肿瘤学。 Proizvodni procesikompanije u skladu su sa standardima sistema upravljanja ISO 9001:2008 i sasmernicama dobre proizvođačke prakse (DPP)/dobre labatorijske prakse (DLP). Iskusan i kvalifikovan tim stručnjaka kompanije Biomedica pruža tehničku inaučnu podrš ku.

Bernard Siow is an MRI physicist at the Center for Advanced Biomedical Imaging (CABI), as well as head of the MRI facility at the Francis Crick Institute.

In an interview, Siow talks about the multimodality approach CABI is taking towards biomedical imaging, as well as the exciting new Crick project that is currently under development.

CABI is a preclinical imaging laboratory that uses around ten different biomedical imaging modalities to look at tissues in different ways. Among the various different modalities are MRI, which the researchers use to examine soft tissue, and computed tomography (CT), which has less soft tissue contrast and is used to look at things like bone structure, for example.

By using different modalities, the scientists can acquire much more information about tissue and pathological parameters than if they used just a single modality. Each modality is associated with various limitations and by using lots of different ones, the scientists find they are less restricted in what they can achieve, performing many different studies across a wide range of diseases.

Originally, CABI housed just one high-field 9.4T MRI scanner, but over the last six years, the center has expanded to accommodate PET/SPECT nuclear imaging, optical projection tomography (OPT), bioluminescent confocal microscopes and the ICON-1T system.

Siow’s main area of interest is a technique called diffusion MRI, which he uses to obtain information about the microstructure of tissues. The MRI voxel on a clinical scanner is around 1 mm in length, whereas the type of spatial information Siow wants to obtain is only around one micron in size.

To get spatial information a thousand times smaller than the size of the voxel, Siow uses diffusion MRI to examine the way water diffuses along cells and estimate, for example, the size of an axon. In particular, axon diameter estimates are important in the diagnosis of many neurodegenerative disease.

Another area Siow looks at that is associated with microstructure is the permeability of cells, which is often abnormal in diseases such as multiple sclerosis.

Siow also talked about the Francis Crick Institute that is currently under construction at Kings Cross, London. As head of the MRI facility, Siow is responsible for developing the imaging areas at the center.

This exciting new project is a collaboration between six establishments – the Wellcome Trust, Cancer Research UK, the Medical Research Council, University College London, Imperial and King’s College, London. The institute plans to employ around 1500 scientists who will be able to work in a very open and collaborative environment where lots of ideas can be exchanged between the various groups of researchers.

Siow says the new center will be very interdisciplinary, looking at preclinical work across various different fields such as cancer research, neurodegenerative disease, cardiac research and infectious disease, to name just a few examples.

Siow graduated from Imperial with a degree in physics. He then completed a master’s degree and PhD in MRI physics in Newcastle before moving to London as a post doc.